Addex Therapeutics (ADXN) Dividends Paid - Common Growth (1y) (2020 - 2026)
Addex Therapeutics (ADXN) Dividends Paid - Common Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 4.54% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -10.39% |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -62.00% |
| Mar 31, 2025 | 68.51% |
| Sep 30, 2024 | 81.48% |
| Jun 30, 2024 | -70.04% |
| Mar 31, 2024 | 30,831,256.32% |
| Sep 30, 2023 | -164,007,584.89% |
| Jun 30, 2023 | 126,407,059.12% |
| Mar 31, 2023 | -62.48% |
| Sep 30, 2022 | 158.37% |
| Jun 30, 2022 | 19.13% |
| Mar 31, 2022 | -42.21% |
| Sep 30, 2021 | 8.00% |
| Jun 30, 2021 | -16.42% |
| Mar 31, 2021 | -0.53% |
| Sep 30, 2020 | 36.27% |
| Jun 30, 2020 | -218.22% |
| Mar 31, 2020 | -28.12% |